Research

Energy balance

One-year discontinuation rates for GLP-1 receptor agonists can be as high as 74% in real-world studies.

Healthcare providers should be aware of the high discontinuation rates of GLP-1 RAs in real-world settings.

StrongSupportsmedium confidence
Real-world studies report one-year discontinuation rates as high as 74%, though substantial variability exists between studies.
Gregory J. Grosicki et al. · Diabetes Obesity and Metabolism · 2025

Why this rating

Based on a systematic review and meta-analysis of real-world studies.

Source

Glucagon‐like peptide‐1 receptor agonists discontinuation is higher in individuals with overweight and obesity without type 2 diabetes

Gregory J. Grosicki et al. · Diabetes Obesity and Metabolism · 2025

DOI 10.1111/dom.16151

Meta-analysisCited 7×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →